Nasdaq Aimd News Today

Ainos (NASDAQ:AIMD – Get Free Report) and NeuroBo Pharmaceuticals (NASDAQ:NRBO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Institutional and Insider Ownership 1.4% of NeuroBo Pharmaceuticals […]

Ainos, Inc. (NASDAQ:AIMD – Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 6,700 shares, a decline of 85.5% from the November 30th total of 46,300 shares. Approximately 0.8% of the company’s stock are sold short. Based […]

Ainos, Inc. (NASDAQ:AIMD – Get Free Report) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 25,800 shares, a drop of 6.9% from the October 31st total of 27,700 shares. Based on an average trading volume of 31,800 shares, the days-to-cover ratio is […]